相关实验视频
Updated: Jul 25, 2025

07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
274
六个潜在的生物标志物在败血症休克:一个深度生物信息学和前性观察研究研究
Chang Kong1, Yurun Zhu2, Xiaofan Xie2
1Department of Anesthesiology and Critical Care Medicine, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, China.
Frontiers in immunology
|June 26, 2023
概括
这项研究确定了六个关键基因 (CD177,CLEC5A,CYSTM1,MCEMP1,MMP8和RGL4),这些基因可以帮助早期诊断败血症休克,改善患者的治疗结果.
科学领域:
- 基因组学就是基因组学.
- 生物标志物发现发现
- 败血症研究 败血症研究
背景情况:
- 败血性休克是一种危及生命的疾病,其特征是严重的低血压,需要早期诊断以减少死亡率.
- 目前的诊断方法有限,单基因生物标志物显示的预测效率不足.
- 需要基于基因特征的强大的风险评分模型来提高诊断准确性.
研究的目的:
- 为了识别新的基因特征,用于早期诊断败血症休克.
- 利用已识别的枢纽基因,开发出感染性休克的预测模型.
- 调查与败血症休克相关的功能途径和免疫细胞透.
主要方法:
- 使用的基因表达数据集 (GSE33118,GSE26440,GSE9692) 来自基因表达综合 (GEO) 数据库.
- 应用差异基因表达分析,拉索回归,博鲁塔特征选择和加权基因共同表达网络分析 (WGCNA).
- 使用接收器运行特征 (ROC) 分析,定量PCR (qPCR) 和西式涂抹验证的诊断值.
主要成果:
- 鉴定了六个枢纽基因 (CD177,CLEC5A,CYSTM1,MCEMP1,MMP8,RGL4) 在败血性休克中表达的显著差异.
- 丰富分析显示了包括ROS,缺氧,PI3K/AKT/mTOR和NF-κβ/TNF-α信号传递在内的途径的参与.
- 证明了高的诊断准确性 (ROC曲线从0.914到0.956不等),并证实了败血性休克患者的mRNA/蛋白质水平升高.
结论:
- 已识别的六个枢纽基因作为有价值的生物标志物,用于早期诊断败血性休克.
- 这些发现提供了关于免疫细胞透在败血症休克病原体的见解.
- 需要进一步的临床和基础研究来验证这些初步结果.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
204
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127

